Nvidia, Pfizer Lead $80 Million Funding for Israeli Medical AI Tech Firm CytoReason

JERUSALEM (Reuters) - Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private...

JERUSALEM (Reuters) - Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private...